Usefulness of examination of some tumor markers in diagnostics of liver cancer

Hepato-Gastroenterology

Volumn 53, Issue 68, 2006, Pages 271-274

  Snarska, Jadwiga ^a   Szajda, Slawomir Dariusz ^a   Puchalski, Zbigniew ^a   Szmitkowski, Maciej ^a   Chabielska, Ewa ^a   Kaminski, Fabian ^a   Zwierz, Piotr ^a   Zwierz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Diagnostics; Liver cancer; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CANCER PROCOAGULANT; CARCINOEMBRYONIC ANTIGEN; PROCOAGULANT; TUMOR MARKER;

ARTICLE; BLOOD CLOTTING TIME; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY CANCER; ECHOGRAPHY; ENZYME IMMUNOASSAY; HUMAN; LIVER CANCER; METASTASIS; PRIORITY JOURNAL; RELAPSE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ALPHA-FETOPROTEINS; BLOOD COAGULATION TESTS; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CASE-CONTROL STUDIES; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 33645559858     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wronkowski Z, Zwierko M, Chmielarczyk W: Epidemiology of malignant cancers in Poland. Medical Guide 2000; 3:12-15.
2. Snarska J, Puchalski Z, Kokoszko M, Hady Razak H, Kilarji A: Malignant and benign tumours of liver - problems of diagnostics, treatment and complications. Annales Academiae Medicae Bialostocensis 2001; 46:158-169.
3. Duffy MJ: Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
4. Dembinska-Kiec A, Noskalski JW: Laboratory diagnostics with the elements of clinical biochemistry. Medical Publishing Office Urban&Partner, Wroclaw 2002.
5. Gordon SG, Franks JJ, Lewis BJ: Comparison of procoagulant activities in extracts of normal and malignant human tissue. J Nat Cancer Inst 1979; 62:773-776.
6. Mielicki WP: Biochemistry of cancer procoagulant. Haemostasis 2001; 31(Suppl 1):8-10.
7. Kozuszko B, Skrzydlewski Z, Sulkowska M, Snarska J, Kozlowski M, Skrzydlewska E, Zalewski B: Activity of cancer procoagulant in esophageal, stomach and colorectal cancers with regard to clinical staging and histological type of cancer. Pol Merk Lek 2001; 63:218-220.
8. Snarska J, Szajda SD, Skrzydlewski Z: Diagnostic usefulness of cancer procoagulant in pancreatic, liver and ovarian cancer. Pol Merk Lek 2003; 15:123-124.
9. Skrzydlewska E, Kozuszko B, Sulkowska M, Zalewski B, Kozlowski M, Snarska J, Puchalski Z, Sulkowski S, Skrzydlewski Z: Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology 2003; 50:126-131.
10. Gordon SG, Benson B: Analysis of serum cancer procoagulant activity and its potential as a tumor marker. Thromb Res 1989; 56:431-440.
11. Grem J: The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract. Curr Opin Oncol 1997; 9:380-387.
12. Kato M, Shinozawa T, Kato S, Terada T: Aberrant expression of a fetal glycoprotein 68 in hepatocellular carcinoma: a comparative study on the expression of alpha-fetoprotein and carcinoembrionic antigen. Histol Histopathol 2004; 19(3):701-706.
13. Kaibori M, Matsui Y, Yanagida H, Yokoigawa N, Kwon AH, Kamiyama Y: Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma. World J Surg 2004; 28(7):702-707.
14. Shawcross DL, Naoumov N, Pachiadakis I, Mamais C, Williams R, Jalan R, Gillams A, Lees W: Should a biopsy precede liver resection or transplantation for presumed hepatocellular carcinoma when the alfa fetoprotein is normal? Trasplantation 2004; 77(4):637-637.
15. Li MS, Li PF, Chen Q, Du GG, Li G: Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. World J Gastroenterol 2004; 10(6):819-824.
16. Yokoo H, Kondo T, Fujii K, Yamada T, Todo S, Hirohashi S: Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology 2004; 40(3):609-617.
17. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC: High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-cathenin mutations. Int J Cancer 2004; 112(1):44-50.
18. Lucha PA, Rosen L, Olenwine JA, Reed JF, Riether RD, Stasik JJ, Khubchandani IT: Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal cancer. Dis Colon Rectum 1997; 40:145-149.
19. Ohlsson B, Tranberg KG, Lundstedt C, Ekberg H, Hederstrom E: Detection of hepatic metastases in colorectal cancer: A prospective study of laboratory and imaging methods. Eur J Surg 1993; 159:275-281.
20. Kozwich DL, Kramer LC, Mielicki WP, Fotopoulos SS, Gordon SG: Applications of cancer procoagulant as an early detection tumor marker. Cancer 1994; 74:1367-1376.